Taitacept Clinical Trials

1 actively recruiting trial

Also known as: No other Intervention Names

Pipeline

Phase 2: 1

Top Sponsors

Beijing Tongren Hospital1

Indications

Anti-N-Methyl-D-Aspartate Receptor Encephalitis1
Cancer1

Other1 trial

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.